agents for the treatment of HIV-1 infection. This indication is based on one principal clinical trial (BI 1090) that demonstrated prolonged suppression of HIV-RNA and two smaller supportive studie....

Antiretroviral, non-nucleoside reverse transcriptase inhibitor (NNRTI) Neonatal ARV prophylaxis of mother-to-child transmission (PMTCT) in high-risk HIV -exposed neonates from 6 weeks of age. Nevirapine is no longer part of the preferred treatment regimens for HIV infection. Some restricted information has been hidden.

2023年10月16日 · Nevirapine is an antiviral medicine that prevents human immunodeficiency virus (HIV) from multiplying in your body. Nevirapine is used to treat HIV, the virus that can cause acquired immunodeficiency syndrome (AIDS). Nevirapine is not a cure for HIV or AIDS, and should not be used to prevent HIV.

The 50 mg tablet should be dispersed in 10 ml of water immediately before administration. NVP is also used for the treatment of HIV-1 infection in children and adults, in combination with other antiretrovirals.

VIRAMUNE is the brand name for nevirapine (NVP), a non-nucleoside reverse transcriptase inhibitor with activity against Human Immunodeficiency Virus Type 1 (HIV-1). Nevirapine is...

2024年1月15日 · Nevirapine is indicated in combination with other antiretroviral agents for the treatment of human immunodeficiency virus (HIV-1) infection in adults and pediatric patients 15 days and older [see ...

Take this medication by mouth with or without food as directed by your doctor, usually once daily for the first 14 days when you start treatment, and then twice daily. If liver problems or skin/allergic reactions occur while you are taking this medication once daily, get medical help right away and do not increase the dose to twice daily.

Indicated for treatment of HIV-1 infection in combination with other antiretrovirals; also used for prevention of maternal-fetal HIV transmission in women with no prior antiretroviral treatment....

Initial Dose (lead-in dosing period): In children up to 2 years of age, some experts start this drug without lead-in dosing. As long as there are no side effects, the mg dose does not need to be decreased when the child reaches 8 years; the mg dose is left the same to achieve the appropriate mg/m2 dosage as the child grows larger.